Table 5.
Characteristics | Coefficient | Exp (coefficient; 95% CI) | P value | Concordance, mean (SE) | |
Age | –0.016 | 0.984 (0.971-0.998) | .02 | 0.589 (–0.019) | |
Country | N/Ab | ||||
|
Spain | —c | — | — |
|
|
Chile | –0.143 | 0.867 (0.588-1.278) | .47 |
|
|
Argentina | 0.091 | 1.096 (0.748-1.605) | .63 |
|
|
Mexico | –0.121 | 0.886 (0.495-1.585) | .68 |
|
|
Colombia | 0.318 | 1.375 (0.797-2.37) | .25 |
|
|
Other | 0.141 | 1.152 (0.779-1.703) | .47 |
|
Anxiety disorder | Yes | 0.233 | 1.262 (0.975-1.634) | .07 | |
Antipsychotic | Yes | 0.334 | 1.396 (1.058-1.843) | .02 |
aSchoenfeld residuals to check the proportional-hazards assumption: age (χ21=0.006; P=.94), anxiety disorder (χ21=2.7; P=.10), and antipsychotic (χ21=0.1; P=.72).
bN/A: not applicable.
cOur Cox model analyzed the risk of discontinuing the app use that participants from different nationalities had in comparison with Spanish participants. This row was maintained in the table to make clear that Spain was not included in the category Other.